Why the study?
Acute pulmonary embolism can cause right heart failure from increased pulmonary vascular resistance and arterial hypoxemia, creating a need for effective pulmonary vasodilator therapy.
Does intravenous PDNO reduce pulmonary vascular resistance and right ventricle rate-pressure product in a rabbit model of acute pulmonary embolism?
Does intravenous PDNO reduce pulmonary vascular resistance and right ventricle rate-pressure product in a rabbit model of acute pulmonary embolism?
PDNO is an efficient NO donor and pulmonary vasodilator that normalizes pulmonary vascular resistance in a rabbit model of acute pulmonary embolism, suggesting potential for preventing right heart failure.
Answers are grounded in this paper and cite their sources.
Supports further PDNO evaluation in pulmonary embolism models; leaves open human translation for right heart failure prevention.
Acute pulmonary embolism may cause right heart failure due to increased pulmonary vascular resistance and arterial hypoxemia. Effective vasodilator therapy of the pulmonary hypertension is highly needed. Therefore, we investigated the effects of a newly developed effective pulmonary vasodilator, the organic mononitrites of 1,2-propanediol (PDNO), in a rabbit model of acute pulmonary embolism. In anesthetized and ventilated rabbits, systemic and pulmonary hemodynamics, exhaled nitric oxide (NO), plasma nitrite concentration, and blood gases were monitored. First, dose-response experiments with intravenous and left heart ventricle infusions of PDNO and inorganic nitrite were done in naive animals and in pulmonary hypertension induced by a thromboxane A₂ analogue. Second, acute pulmonary embolism was induced and either PDNO or placebo were administered intravenously within 20 minutes and evaluated within 1 hour after pulmonary embolization. PDNO intravenously, in contrast to inorganic nitrite intravenously, increased exhaled NO and counteracted pulmonary hypertension and vasodilated the systemic circulation, dose-dependently, thereby showing efficient NO donation. Pulmonary embolization induced pulmonary hypertension and gas exchange disturbances. PDNO significantly decreased and normalized pulmonary vascular resistance and the right ventricle rate-pressure product, without causing tolerance, with no significant side effects on the systemic circulation, nor on blood-gas values or on methemoglobin formation. In conclusion, PDNO is a NO donor and an efficient vasodilator in the pulmonary circulation. Treatment with this or similar organic nitrites intravenously may be a future option to avoid right heart failure in life-threatening acute pulmonary embolism.
No takes yet. Share an insight, caveat, or question.
Nilsson et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: